Lantheus CMO Jeff Humphrey to depart Jan 3, 2025; search underway for replacement

Lantheus Holdings, Inc.

Jeff Humphrey, MD, resigns as Chief Medical Officer; last day January 3, 2025.
Departure not due to disagreement with company or board on operations, clinical programs, or policies.
CEO Brian Markison and President Paul Blanchfield assume interim leadership of R&D.
Company has initiated a search for a new Chief Medical Officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.